Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Storage requirements vary by product
In one clinical trial published in The New England Journal of Medicine in 2016, patients with obesity and type 2 diabetes lost an average of 10.8 pounds and lowered their A1C (a measurement of average blood sugar levels) by 1.4 percent after taking 1 mg of semaglutide for 104 weeks (8)
K.et al (2009)
Cagrilintide works through the amylin pathway, offering a different mechanism entirely
By combining three powerful mechanisms in one therapy, it demonstrates how multi-receptor peptides can deliver broader, more durable results than ever before
Kahl S, Gancheva S, Strassburger K et al (2020) Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
US$ 26.47
US$ 24.34
US$ 28.79
US$ 27.82
US$ 24.75
US$ 23.99
